Clinical Trial Update: To Evaluate if Dexmedetomidine Infusion Provides Renal Protection in Patients Undergoing Coronary Artery Bypass Graft [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating whether dexmedetomidine infusion provides renal protection in patients undergoing coronary artery bypass graft; phases 2/3 completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: National Institute of Cardiovascular Diseases, Pakistan | Conditions: Acute Kidney Injury | Phase 2, Phase 3 | Status: COMPLETED